Hematologie nieuws
- European Commission grants conditional marketing authorization to Pfizer's gene therapy, Durveqtix for adults with haemophilia B
- Autumn date to fix blood transfusion services
- The hematopoietic stem cell expansion niche in fetal liver: current state of the art and the way forward
- Prehospital transfusion of labile blood product using intraosseous perfusion with multi?lumen extender: Why not?
- Robustness assessment of an automated AI?based white blood cell morphometric analysis system using different smear preparation methods
- Pfizer announces positive topline results from phase 3 AFFINE study of haemophilia A gene therapy candidate
- Novel neutrophil biology insights underlying atypical chemokine receptor-1/Duffy antigen receptor of chemokines-associated neutropenia
- Antiphospholipid Antibodies in Mental Disorders
- Anti?HNA testing of allo?exposed COVID?19 convalescent plasma donors including genetic human neutrophil antigen screening to prevent anti?HNA antibody?mediated transfusion?related acute lung injury
- Fatal posterior reversible encephalopathy syndrome after blood transfusion in a patient with myelodysplastic syndromes
- Determining the strength of evidence for an association between sexual indicators and risk of acquiring HIV and sexulaly transmitted infections: Providing evidence for blood donation policy change
- Mechanistic and Biological Perspectives on Erythropoiesis
- Doctors at Sahyadri Hospitals Pune warn of rising pulmonary embolism cases linked to international travel
- Laboratory Diagnostics for Thrombosis and Hemostasis Testing—Part 3
- Genetic variation of FUT3 gene in the Han population from Northern China